角膜移植市场规模、份额及成长分析（按类型、适应症、最终用户和地区划分）－2026-2033年产业预测

预计到 2024 年，角膜移植市场规模将达到 5.2674 亿美元，到 2025 年将达到 5.6624 亿美元，到 2033 年将达到 10.0988 亿美元，在预测期（2026-2033 年）内，复合年增长率为 7.5%。

市场分析显示，角膜移植在圆锥角膜的治疗中发挥至关重要的作用，约有10-15%的患者最终需要接受此项手术。这凸显了角膜移植在控制这种影响全球众多患者的疾病中的重要角色。此外，角膜盲已被公认为重要的公共卫生问题，是继青光眼和白内障之后失明的第三大原因。全球约有1000万人受到影响，凸显了寻找有效角膜健康解决方案的迫切性。人们对这一问题的日益关注可能会推动对角膜移植手术的需求，使其成为眼科市场的重要组成部分，并强调持续改进治疗方案的必要性。

角膜移植市场驱动因素

全球角膜移植市场的主要驱动因素之一是导致视力障碍和角膜盲的眼科疾病和病症的增加。人口老化、糖尿病盛行率上升以及环境因素等因素导致需要角膜移植的患者数量不断增加，从而提高了对有效手术治疗方法的需求。此外，手术技术的进步和术后护理的改善提高了移植成功率，进一步激励了患者和医疗机构选择角膜移植手术。这种日益增强的认知和不断改善的治疗效果是推动市场成长的关键因素。

限制角膜移植市场的因素

全球角膜移植市场面临的主要限制因素之一是供体角膜短缺。合适的捐赠者组织数量有限，会限制移植手术的成功率，影响患者预后和整体市场成长。此外，与器官捐赠相关的严格法规和伦理考量也会使取得过程变得复杂。这种短缺会导致患者等待时间延长，造成患者沮丧，并可能加重视力障碍。此外，角膜移植手术和术后护理的高昂费用也会使患者和医疗机构对这项救命手术望而却步，进一步限制市场扩张。

角膜移植市场趋势

角膜移植市场正经历显着成长，这主要得益于多种因素的共同作用，推动了对创新医疗解决方案的需求。角膜移植技术的进步显着改善了多种眼科疾病的治疗效果，使其成为患者和医疗机构的首选治疗方案。此外，人口老化加剧，罹患福克斯角膜营养不良等眼科疾病的风险也随之增加，进一步推动了市场扩张。这种人口结构的变化不仅增加了对角膜移植的需求，也刺激了研发投入，从而改善了眼科领域的治疗效果，并提高了医疗服务的可及性。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 技术分析

全球角膜移植市场规模（按类型及复合年增长率划分）（2026-2033 年）

• 穿孔性角膜移植术
• 内皮移植
• Descemet 细胞自动内皮移植 (DSAEK)
• 角膜移植
• 角膜缘干细胞移植
• 其他的

全球角膜移植市场规模（按适应症和复合年增长率划分）（2026-2033 年）

• 真菌性角膜溃疡
• 水痘角膜疾病
• 圆锥角膜
• 角膜炎
• 角膜基质营养不良
• 其他的

全球角膜移植市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 眼科诊所
• 其他的

全球角膜移植市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• CorneaGen（USA）
• Eversight（USA）
• Lions VisionGift（USA）
• Keramed Inc.（USA）
• EyeYon Medical（Israel）
• Aurolab（India）
• Presbia PLC（Ireland）
• Mediphacos（Brazil）
• DIOPTEX GmbH（Austria）
• AJL Ophthalmic SA（Spain）
• Florida Lions Eye Bank（USA）
• Ocular Systems Inc.（USA）
• Gebauer Medizintechnik GmbH（Germany）
• Tomey Corporation（Japan）
• SightLife（USA）
• Ampleye（Netherlands）
• Allotex（USA）
• Eye Bank Association of America（EBAA）（USA）
• Boston Keratoprosthesis（Boston KPro）（USA）
• IOPtima Ltd.（Israel）

结论与建议

Corneal Transplant Market size was valued at USD 526.74 Million in 2024 and is poised to grow from USD 566.24 Million in 2025 to USD 1009.88 Million by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

Market insights reveal that corneal transplants play a crucial role in treating keratoconus, with 10-15% of patients eventually requiring this surgical intervention. This highlights the essential nature of corneal implants in managing the condition, which affects a significant number of individuals globally. Furthermore, corneal blindness is recognized as a major public health issue, being the third leading cause of blindness after glaucoma and cataracts. Approximately 10 million people are affected worldwide, emphasizing the urgent need for effective solutions in corneal health. The increasing awareness of these issues is likely to drive demand for corneal transplant procedures, positioning them as a vital component in the ophthalmology market and underscoring the need for continued advancements in treatment options.

Top-down and bottom-up approaches were used to estimate and validate the size of the Corneal Transplant market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Corneal Transplant Market Segments Analysis

Global Corneal Transplant Market is segmented by Type, Indications, End-User and region. Based on Type, the market is segmented into Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Corneal Graft, Corneal Limbal Stem Cell Transplant and Others. Based on Indications, the market is segmented into Fungal Corneal Ulcer, Bullous Keratopathy, Keratoconus, Keratitis, Corneal Stromal Dystrophies and Others. Based on End-User, the market is segmented into Hospital, Eye Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Corneal Transplant Market

One of the key market drivers for the global corneal transplant market is the increasing prevalence of ocular diseases and conditions that lead to vision impairment and corneal blindness. As factors such as the aging population, rising incidence of diabetes, and environmental influences contribute to a growing number of patients requiring corneal transplants, there is an enhanced demand for effective surgical solutions. Additionally, advancements in surgical techniques and post-operative care have improved transplant success rates, further encouraging patients and healthcare providers to pursue corneal transplant procedures. This heightened awareness and improved outcomes are vital in driving market growth.

Restraints in the Corneal Transplant Market

One significant market restraint for the global corneal transplant market is the shortage of donor corneas. The limited availability of suitable donor tissues can hinder the volume of successful transplant surgeries, impacting patient outcomes and overall market growth. Furthermore, stringent regulations and ethical considerations surrounding organ donation can complicate the procurement process. This scarcity leads to prolonged waiting periods for patients, contributing to dissatisfaction and potentially worsening visual impairment. Additionally, the high costs associated with corneal transplantation procedures and follow-up care may deter patients and healthcare providers from pursuing these lifesaving interventions, further constraining market expansion.

Market Trends of the Corneal Transplant Market

The corneal transplant market is experiencing remarkable growth driven by a confluence of factors that enhance the demand for innovative medical solutions. Technological advancements in corneal implants have significantly improved their effectiveness in treating a variety of eye disorders, making them a preferred choice for both patients and healthcare providers. Additionally, the rising geriatric population, with increasing susceptibility to eye conditions such as Fuchs' dystrophy, further fuels market expansion. This demographic shift not only heightens the need for corneal transplants but also fosters investments in research and development, leading to better treatment outcomes and greater accessibility in ophthalmology.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis

Global Corneal Transplant Market Size by Type & CAGR (2026-2033)

• Market Overview
• Penetrating Keratoplasty
• Endothelial Keratoplasty
• Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
• Corneal Graft
• Corneal Limbal Stem Cell Transplant
• Others

Global Corneal Transplant Market Size by Indications & CAGR (2026-2033)

• Market Overview
• Fungal Corneal Ulcer
• Bullous Keratopathy
• Keratoconus
• Keratitis
• Corneal Stromal Dystrophies
• Others

Global Corneal Transplant Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospital
• Eye Clinics
• Others

Global Corneal Transplant Market Size & CAGR (2026-2033)

• North America (Type, Indications, End-User)
  • US
  • Canada
• Europe (Type, Indications, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Indications, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Indications, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Indications, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• CorneaGen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eversight (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lions VisionGift (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Keramed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EyeYon Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurolab (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Presbia PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediphacos (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DIOPTEX GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AJL Ophthalmic S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Florida Lions Eye Bank (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ocular Systems Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gebauer Medizintechnik GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tomey Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SightLife (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ampleye (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allotex (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eye Bank Association of America (EBAA) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Keratoprosthesis (Boston KPro) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IOPtima Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations